MEDIBANK PRIVATE LIMITED (MPL)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

MPL - MEDIBANK PRIVATE LIMITED

FNArena Sector : Insurance
Year End: June
GICS Industry Group : Insurance
Debt/EBITDA: N/A
Index: ASX50 | ASX100 | ASX200 | ASX300 | ALL-ORDS

Medibank Private is the largest Australian private health insurance provider. Previously an Australian Government business enterprise, established by the Whitlam government in 1975, it was privatised in 2014.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$3.39

03 Oct
2023

-0.050

OPEN

$3.42

-1.45%

HIGH

$3.44

8,360,061

LOW

$3.39

TARGET
$3.765 11.1% upside
Franking for last dividend paid out: 100%
OTHER COMPANIES IN THE SAME SECTOR
AUB . CVW . FCL . GDG . HLI . IAG . NHF . NOL . PSI . QBE . SDF . SUN . TWR .
FNARENA'S MARKET CONSENSUS FORECASTS
MPL: 1
Title FY22
Actual		 FY23
Actual		 FY24
Forecast		 FY25
Forecast
EPS (cps) xxx 18.6 19.9 xxx
DPS (cps) xxx 14.6 16.1 xxx
EPS Growth xxx 29.8% 7.0% xxx
DPS Growth xxx 9.0% 10.2% xxx
PE Ratio xxx N/A 17.1 xxx
Dividend Yield xxx N/A 4.7% xxx
Div Pay Ratio(%) xxx 78.7% 81.0% xxx

Dividend yield today if purchased 3 years ago: 5.55%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

 4.31

Estimated Dividend Growth
(Average Of Past Three Years)

  %

Amount Invested

 $ 

Tell Me The Dividend After This Many Years
Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 13/09 - ex-div 8.3c (franking 100%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2023 FactSet UK Limited. All rights reserved
Title 201820192020202120222023
EPS Basic xxxxxxxxxxxxxxx18.6
DPS All xxxxxxxxxxxxxxx14.6
Sales/Revenue xxxxxxxxxxxxxxx7,460.1 M
Book Value Per Share xxxxxxxxxxxxxxx75.7
Net Operating Cash Flow xxxxxxxxxxxxxxx258.2 M
Net Profit Margin xxxxxxxxxxxxxxx6.85 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201820192020202120222023
Return on Capital Employed xxxxxxxxxxxxxxx25.36 %
Return on Invested Capital xxxxxxxxxxxxxxx24.93 %
Return on Assets xxxxxxxxxxxxxxx11.43 %
Return on Equity xxxxxxxxxxxxxxx25.36 %
Return on Total Capital xxxxxxxxxxxxxxx35.16 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx-124.1 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201820192020202120222023
Short-Term Debt xxxxxxxxxxxxxxx31 M
Long Term Debt xxxxxxxxxxxxxxx24 M
Total Debt xxxxxxxxxxxxxxx55 M
Goodwill - Gross xxxxxxxxxxxxxxx283 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx421 M
Price To Book Value xxxxxxxxxxxxxxx4.65

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201820192020202120222023
Capex xxxxxxxxxxxxxxx41.9 M
Capex % of Sales xxxxxxxxxxxxxxx0.56 %
Cost of Goods Sold xxxxxxxxxxxxxxx-
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx869 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx2,878 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.2

No. Of Recommendations

6
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Morgan Stanley

xx/xx/xxxx

3

xxxxx-xxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Ord Minnett

xx/xx/xxxx

3

xxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgans

xx/xx/xxxx

3

xxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Macquarie

25/08/2023

3

Neutral

$3.75

10.62%

Medibank Private's FY23 result beat Macquarie's forecasts on both profit and margin, thanks to a combination of productivity savings and policyholder growth.

Average net claims per policy unit rose 2.6% and cyber-crime costs related to upgrades and class action took a toll and the broker expects the cyber-crime costs will continue into FY24.

EPS forecasts rise 7.9% in FY24, 9.6% in FY25 and 2.5% to 7.7% thereafter.

Neutral rating retained. Target price rises to $3.75 from $3.50.

FORECAST
Macquarie forecasts a full year FY24 dividend of 15.00 cents and EPS of 19.50 cents.
Macquarie forecasts a full year FY25 dividend of 17.90 cents and EPS of 20.40 cents.

Citi

xx/xx/xxxx

3

xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

UBS

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial
Access Stockbroker Research History >

MPL STOCK CHART

FNArena News on MPL

1
ESG Focus: The Little Big Things – 27-09-2023

Sep 27 2023 - ESG Focus
2
Rudi’s Views: August 2023 – Winners & Losers

Sep 13 2023 - Rudi's View
3
Australian Broker Call *Extra* Edition – Aug 31, 2023

Aug 31 2023 - Daily Market Reports
4
Australian Broker Call *Extra* Edition – Aug 30, 2023

Aug 30 2023 - Daily Market Reports
5
FNArena Corporate Results Monitor – 25-08-2023

Aug 25 2023 - Australia

Latest Insurance News

1
Pros And Cons Of Insurance Companies

Aug 02 2023 - Australia
2
Underlying Trends Positive For QBE Insurance

May 15 2023 - Australia
3
Rates Over Reinsurance For General Insurers 

Feb 01 2023 - Australia
4
Climate Costs Burden Heaviest For Aussie Insurers

Jun 01 2022 - Australia
5
In Brief: Risks From Russia, House Prices And Insurance Brokers

Feb 04 2022 - Australia
6
IAG Fails The Weather Test, But All Is Not Lost

Nov 03 2021 - Australia
7
Growth Returns For Suncorp

Aug 10 2021 - Australia
8
Treasure Chest: IAG Re-Rating?

Jun 28 2021 - Treasure Chest
9
Insurers Grapple With Costs And Competition

Jun 16 2021 - Australia
10
Nib Holdings May Need To Tread Carefully

Apr 27 2021 - Australia